AbbVie Inc. CDR (ABBV)
TSX
Closed
Oct 9, 2026
Day's Range
38.0752 wk Range
26.89Overview - ABBV - AbbVie Inc. CDR
Key Statistics
Valuation
Enterprise Value
703.14B
P/E (Trailing)
‪69.30‬
PEG Ratio
‪0.24‬
Price / Sales (TTM)
‪10.47‬
Price / Book
‪-104.15‬
EV / EBITDA
‪30.97‬
Profitability
Gross Margin
‪74.74%‬
Profit Margin
‪70.23%‬
Operating Margin
‪15.51%‬
Return on Assets
‪3.12%‬
Return on Equity
‪-129.67%‬
Ownership
Shares Outstanding
1.76B
Price stats
50-Day Avg
‪35.77‬
200-Day Avg
‪32.26‬
Dividends
Frequency
Quarterly
Market Cap - ABBV - AbbVie Inc. CDR
Peers - ABBV - AbbVie Inc. CDR
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on TSX.
- ABBVTSXAbbVie Inc. CDR640.88BMarket Cap+13.80%52-week change69.30P/E (Trailing)‪70.23%‬Profit Margin
- LLYTSXEli Lilly CDR1.45TMarket Cap+37.24%52-week change37.05P/E (Trailing)‪83.04%‬Profit Margin
- JNJTSXJohnson & Johnson630.04BMarket Cap+26.98%52-week change30.25P/E (Trailing)‪21.48%‬Profit Margin
- ROGTSXRoche Holding AG American Depositary Receipt524.02BMarket Cap+20.55%52-week change22.31P/E (Trailing)‪73.72%‬Profit Margin
- MRKTSXMerck & Co., Inc.509.66BMarket Cap+46.01%52-week change118.14P/E (Trailing)‪74.80%‬Profit Margin
- AMGNTSXAmgen Inc. Canadian Depositary Receipt304.51BMarket Cap+18.18%52-week change24.46P/E (Trailing)‪67.24%‬Profit Margin
- GILDTSXGilead Sciences Inc. Canadian Depositary Receipt243.85BMarket Cap+15.67%52-week change17.00P/E (Trailing)‪78.82%‬Profit Margin
Profile Summary - ABBV - AbbVie Inc. CDR
About
AbbVie Inc. CDR is a Canadian Depositary Receipt that provides Canadian investors with exposure to AbbVie Inc., a research-based biopharmaceutical company, trading in Canadian dollars with a currency hedge to minimize foreign exchange risk. AbbVie Inc. engages in the discovery, development, manufacturing, and sale of…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
